Cartesian Therapeutics(RNAC) - 2020 Q3 - Earnings Call Transcript

Selecta Biosciences, Inc. (SELB) Q3 2020 Earnings Conference Call November 5, 2020 8:30 AM ET Company Participants Brad Dahms - Chief Financial Officer Carsten Brunn - President and Chief Executive Officer Peter Traber - Chief Medical Officer Takashi Kishimoto - Chief Scientific Officer Conference Call Participants John Newman - Canaccord Genuity Corp. Kristen Kluska - Cantor Fitzgerald & Co. Raju Prasad - William Blair & Company, LLC Daniel Clark - Mizuho Securities USA LLC Operator Good morning and welcom ...